Gemcitabine

Overview

Gemcitabine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL888).

API suppliers (26)

Suppliers of Gemcitabine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• SHILPA PHARMA LIFESCIENCES LTD2 active DMF
• ARCH PHARMALABS LTD2 active DMF
• Intas Pharmaceuticals Ltd.India2 active DMF
• Emcure Pharmaceuticals LimitedIndia2 active DMF
• Laurus Labs LimitedIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• Jiangsu Hansoh Pharmaceutical Group Company LimitedChina1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• Jiangsu Hansoh Pharmaceutical Group Company LimitedChina1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Laurus Labs LimitedIndia1 active DMF
• Hetero Labs LimitedIndia1 active DMF
• Jiangsu Hansoh Pharmaceutical Group Company LimitedChina1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Hetero Labs LimitedIndia1 active DMF
• Laurus Labs LimitedIndia1 active DMF
• BENZOCHEM LIFESCIENCES PVT LTD
• Zhejiang Hisun Pharmaceutical Co., Ltd.China
• Cipla USA, Inc.USA
• Cadila Healthcare LimitedIndia

Showing 25 of 26 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (41 approved US products), the latest listed US patent on Gemcitabine expires 18 Aug 2034 and exclusivity 8 Sept 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

Canonical SMILES

C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F

InChIKey

SDUQYLNIPVEERB-QPPQHZFASA-N